Since staging cancer is key to determining its treatment path, one crucial factor is understanding how aggressive the cancer is, and that's where the Gleason grading system comes in.

National guidelines on prostate cancer screening with the PSA test are set by the U.S. Preventive Services Task Force (USPSTF ...

The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still ...

Michael, David, Paul – the names of just three of our readers who have had to take matters into their own hands when it comes ...

While the agency reports rates for new prostate cancer cases have been rising an average 1.8% each year over from 2013 to 2022, death rates have been falling on average 0.6% each year over between ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...

Prostate cancer is the second most common cancer in men, affecting 1 in 8 men in the U.S., according to the American Cancer Society. Here's what you need to know about the disease. Need a break?